Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$976,793
-$225,988 QoQ
Shares Held
159,607
-8.3% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. VNDA ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $976,793 | 159,607 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,202,781 | 174,064 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,084,815 | 122,995 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $704,861 | 141,255 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $812,612 | 172,164 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $940,783 | 204,964 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,093,786 | 228,348 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,063,423 | 226,743 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,714,882 | 303,519 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,358,925 | 330,639 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $569,649 | 134,988 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $628,589 | 145,507 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,390,909 | 362,809 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,504,414 | 368,839 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,654,819 | 359,245 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,999,705 | 303,614 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,359,956 | 308,253 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,601,385 | 318,425 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,814,287 | 306,838 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,461,180 | 318,622 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 1,052,026 | Shares | Defined | 2021-08-17 | |
| 2021-06-30 | $7,104,300 | 330,279 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 ALXN | — | 1,139,063 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $4,825,925 | 321,300 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 ALXN | — | 1,148,314 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $4,293,166 | 326,725 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 ALXN | — | 1,051,519 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $3,517,041 | 364,083 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 ALXN | — | 984,321 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $20,681,117 | 1,807,790 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 1,219,336 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $3,379,265 | 326,184 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||